• AO/PI Staining Solution: Precision Fluorescent Cell Viabilit

  2026-04-25

  AO/PI Staining Solution enables robust, interference-free live/dead cell discrimination by leveraging dual fluorescent DNA dyes. Its precision and adaptability make it the reagent of choice for high-fidelity cell viability and apoptosis studies, especially in research demanding reproducible, mechanistically insightful data.

• Bovine Insulin in Cell Culture: Protocols, Workflows & Optim

  2026-04-24

  Bovine insulin is a precision tool for boosting cell proliferation and metabolic control in culture applications. This article translates recent advances and rigorous protocols into actionable strategies, ensuring reproducible, high-sensitivity results for demanding biomedical assays. Discover how APExBIO’s product quality and workflow alignment set a new standard for experimental robustness.

• (-)-JQ1: The Inactive Stereoisomer Elevating BET Inhibitor R

  2026-04-24

  (-)-JQ1, the inactive JQ1 stereoisomer, is the gold-standard control for dissecting BET bromodomain function in cancer epigenetics research. Learn how precise workflows and troubleshooting can maximize data fidelity and interpretability in BRD4-targeted assays.

• Vacuolin-1: Precision Lysosomal Exocytosis Inhibitor Workflo

  2026-04-23

  Vacuolin-1 empowers cell biologists to dissect Ca2+-dependent lysosomal exocytosis with unmatched selectivity, enabling robust studies of membrane repair, trafficking, and signaling. This article delivers actionable protocols, troubleshooting, and workflow enhancements to maximize Vacuolin-1’s impact in experimental models, with direct translation from breakthrough cartilage pathology research.

• Perineuronal Net Degradation Drives Social Memory Loss in AD

  2026-04-23

  This study reveals that degradation of perineuronal nets (PNNs) in the hippocampal CA2 region underlies social memory deficits in Alzheimer’s disease (AD) models. By identifying matrix metalloproteinases (MMPs) as key mediators of PNN loss and demonstrating that MMP inhibition preserves social cognition, the work highlights the extracellular matrix as a promising therapeutic target in AD.

• Filipin III: Gold-Standard Cholesterol Detection Reagent

  2026-04-22

  Filipin III, a polyene macrolide antibiotic, is widely recognized for its specificity in detecting cholesterol within biological membranes. It enables ultrastructural visualization and quantification of cholesterol-rich microdomains, supporting advanced research in cell biology and membrane biochemistry.

• Reversine (A3760): Practical Guidance for Aurora Kinase Inhi

  2026-04-22

  Reversine is a nanomolar-potency Aurora kinase inhibitor designed for in vitro and in vivo research on mitotic regulation and cancer cell proliferation inhibition. It is best suited for bench workflows targeting Aurora kinase A, B, and C, but should not be used for diagnostic or therapeutic applications. Proper solubilization and storage practices are essential to ensure experimental reliability.

• Filipin III: Precision Cholesterol Detection in Membrane Res

  2026-04-21

  Filipin III, a polyene macrolide antibiotic from APExBIO, remains the gold-standard probe for cholesterol detection in biological membranes. This article details actionable workflows, troubleshooting insights, and the translational impact of Filipin III, drawing on cutting-edge metabolic liver disease research.

• Probenecid in Translational Research: Mechanistic Insights &

  2026-04-21

  This thought-leadership article explores the multifaceted mechanistic roles of Probenecid (4-(dipropylsulfamoyl)benzoic acid) as an MRP and pannexin-1 channel inhibitor. Bridging multidrug resistance, immunometabolic modulation, and neuroprotection, it synthesizes recent immunology breakthroughs with strategic guidance for translational researchers. Distinct from standard product pages, this piece contextualizes Probenecid’s utility in advanced experimental workflows, highlights its integration in precision medicine, and offers protocol parameters and outlook for future research.

• Mubritinib (TAK 165): Mitochondrial Targeting in Oncology

  2026-04-20

  Explore how Mubritinib (TAK 165) is redefining targeted therapy by inhibiting mitochondrial complex I, moving beyond historical HER2 paradigms. This article delivers mechanistic clarity, protocol guidance, and strategic insights for translational researchers aiming to leverage metabolic vulnerabilities in chemotherapy-resistant cancers.

• 0.4% Trypan Blue Solution: Practical Guide for Cell Viabilit

  2026-04-20

  The 0.4% Trypan Blue Solution is a reliable azo dye for cell staining, enabling rapid and accurate cell viability measurement in cell culture workflows. It should be used for distinguishing live from dead cells in research assays, but is not suitable for diagnostic or medical applications. This article details actionable parameters, setup guidance, and troubleshooting to ensure reproducible results.

• Resveratrol Inhibits CAF-Driven Breast Cancer Organoid Growt

  2026-04-19

  This study establishes a co-culture model of patient-derived breast cancer organoids and cancer-associated fibroblasts (CAFs) to examine the protective role of CAFs against therapy and the inhibitory effects of resveratrol. The research demonstrates that resveratrol suppresses organoid growth and reduces VCAN expression in CAFs, highlighting the importance of tumor microenvironment modeling in preclinical drug evaluation.

• Streamlining Macrolide Antibiotic Production via 3-O-AT Dele

  2026-04-18

  This study demonstrates the targeted in-frame partial deletion of the 3-O-acyltransferase gene (sspA) in Streptomyces spiramyceticus WSJ-1, resulting in a streamlined strain (WSJ-2) that exclusively produces 400-isovalerylspiramycin I. The findings offer a blueprint for simplifying macrolide antibiotic component profiles, which has significant implications for both industrial production and the study of structure-activity relationships in antibacterial agents.

• GSK-923295: Rethinking Mitotic Control for Translational Imp

  2026-04-17

  This thought-leadership article dissects the mechanistic basis and translational potential of GSK-923295, a leading CENP-E inhibitor, for cancer research. Integrating the latest findings on centromere biology and mitotic fidelity, it provides actionable guidance for researchers aiming to leverage cell cycle arrest in mitosis and antitumor activity in colon cancer xenografts. By contextualizing APExBIO’s GSK-923295 within the current competitive landscape and referencing both foundational studies and workflow resources, the article empowers translational scientists to design, interpret, and advance preclinical models targeting mitotic kinesins.

• Lipo3K Transfection Reagent: High-Efficiency Gene Delivery S

  2026-04-16

  Lipo3K Transfection Reagent empowers robust gene expression and RNA interference workflows, even in challenging cell types. Its low cytotoxicity and unique enhancement chemistry support reproducible results for co-transfection, gene silencing, and resistance mechanism studies.

15507 records 1/1034 page Next 12345 下5页 Last page